newsfilter
← Latest News
Business Wire·

Canopy Growth Expands European Medical Cannabis Supply Into the UK

  • Canopy Growth Corporation will supply four Canadian-grown medical cannabis flower strains to the UK medical market via Spectrum Therapeutics.
  • The strains will be distributed by GROW Group U.K. Ltd., which will commercialize the products under Canopy Growth's global Spectrum Therapeutics brand.
  • This agreement marks the initial entry of Canopy Growth's portfolio into the United Kingdom, expanding its European medical cannabis business.
  • The supply is supported by Canopy Growth's recent renewal of EU GMP certification at its Kincardine, Ontario cultivation facility.
  • CEO Luc Mongeau stated the expansion leverages established EU GMP capabilities and growing demand across European medical markets.